×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Agios Pharmaceuticals (NASDAQ:AGIO) Downgraded by StockNews.com to “Sell”
Defense World
Read Agios Pharmaceuticals (NASDAQ:AGIO) Downgraded by StockNews.com to “Sell” at Defense World.
9 hours ago
EHA Preview: Agios Takes Spotlight In Thalassemia
Scrip
The company expects to have data from transfusion-dependent and non-transfusion dependent patients this year, with a potential expanded US approval in 2025...
5 days ago
Agios' Tibsovo Gets FDA Priority Review in First-Line Cancer
Yahoo News New Zealand
Agios' (AGIO) label expansion filing eyes an approval of Tibsovo for newly diagnosed acute myeloid leukemia patients with an IDH1 mutation.
2 days ago
With trial win for oral thalassemia drug, Agios charts broader path than gene therapy rivals
Fierce Pharma
Gene therapies have been approved for certain patients with beta thalassemia. After a successful phase 3 readout, Agios hopes it can reach a...
4 months ago
Attention Biotech Investors - Stocks To Watch - Agios Pharmaceuticals (NASDAQ:AGIO), Corbus Pharmaceutica
Benzinga
RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming binary catalysts,...
4 days ago
Agios' Pyrukynd coming from behind with new uses?
BioWorld MedTech
Agios Pharmaceuticals Inc.'s fourth-quarter and full-year 2023 financial report in mid-February highlighted further prospects with Pyrukynd...
1 month ago
Agios's mitapivat meets endpoints in Phase III thalassemia trial
Clinical Trials Arena
Mitapivat is a pyruvate kinase activator, which was approved as a treatment for haemolytic anaemia in adults with pyruvate kinase deficiency in...
4 months ago
Agios Aces Phase III Study in Adults with Alpha- or Beta-Thalassemia
BioSpace
Agios Pharmaceuticals met the primary endpoint in a late-stage trial investigating its drug mitapivat in treating adults with...
4 months ago
Minor mag. 1.9 earthquake - Aegean Sea, 10.6 km southeast of Nisi Agios Efstratios Island, Greece, on Saturday, May ...
VolcanoDiscovery
Detailed info, map, data, reports, updates about this earthquake: Minor mag. 1.9 earthquake - Aegean Sea, 10.6 km southeast of Nisi Agios...
2 days ago
Agios' next-up PK activator quelled transfusion need in select patients, teeing up placebo test
Fierce Biotech
The rare disease company reported Monday that “proof-of-concept has been achieved” in a phase 2a study of AG-946, a pyruvate kinase (PK)...
6 months ago